Patents by Inventor Jean-Baptiste Arlin

Jean-Baptiste Arlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID FORMS AND COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
    Publication number: 20240101580
    Abstract: Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.
    Type: Application
    Filed: September 27, 2023
    Publication date: March 28, 2024
    Inventors: Christopher J. BURNS, Daniel C. PEVEAR, Luigi XERRI, Timothy HENKEL, Daniel MCGARRY, Lawrence ROSEN, Gerald BRENNER, Jean-Baptiste ARLIN, Ana FERNANDEZ CASARES
  • Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
    Patent number: 11820784
    Abstract: Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.
    Type: Grant
    Filed: June 21, 2021
    Date of Patent: November 21, 2023
    Assignee: VENATORX PHARMACEUTICALS, INC.
    Inventors: Christopher J. Burns, Daniel C. Pevear, Luigi Xerri, Timothy Henkel, Daniel McGarry, Lawrence Rosen, Gerald Brenner, Jean-Baptiste Arlin, Ana Fernandez Casares
  • SOLID FORMS AND COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
    Publication number: 20220002322
    Abstract: Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.
    Type: Application
    Filed: June 21, 2021
    Publication date: January 6, 2022
    Inventors: Christopher J. BURNS, Daniel C. PEVEAR, Luigi XERRI, Timothy HENKEL, Daniel MCGARRY, Lawrence ROSEN, Gerald BRENNER, Jean-Baptiste ARLIN, Ana FERNANDEZ CASARES
  • Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
    Patent number: 11091505
    Abstract: Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 17, 2021
    Assignee: VenatoRx Pharmaceuticals, Inc.
    Inventors: Christopher J. Burns, Daniel C. Pevear, Luigi Xerri, Timothy Henkel, Daniel McGarry, Lawrence Rosen, Gerald Brenner, Jean-Baptiste Arlin, Ana Fernandez Casares
  • TYK2 inhibitors, uses, and methods for production thereof
    Patent number: 11040967
    Abstract: The present invention provides compounds of formula I useful as inhibitors of Tyrosine Kinase 2 (Tyk2) solid forms and compositions thereof, methods of producing the same, and methods of using the same in the treatment of Tyk2-mediated diseases.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: June 22, 2021
    Assignee: Nimbus Lakshmi, Inc.
    Inventors: Jeremy Robert Greenwood, Craig E. Masse, Jon P. Lawson, Jean-Baptiste Arlin, David Pearson, Jonathan James Loughrey
  • SOLID FORMS AND COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
    Publication number: 20200010485
    Abstract: Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.
    Type: Application
    Filed: March 5, 2018
    Publication date: January 9, 2020
    Inventors: Christopher J. BURNS, Daniel C. PEVEAR, Luigi XERRI, Timothy HENKEL, Daniel MCGARRY, Lawrence ROSEN, Gerald BRENNER, Jean-Baptiste ARLIN, Ana FERNANDEZ CASARES
  • TYK2 INHIBITORS, USES, AND METHODS FOR PRODUCTION THEREOF
    Publication number: 20190337941
    Abstract: The present invention provides compounds useful as inhibitors of Tyrosine Kinase 2 (Tyk2), solid forms and compositions thereof, methods of producing the same, and methods of using the same in the treatment of Tyk2-mediated diseases.
    Type: Application
    Filed: May 21, 2019
    Publication date: November 7, 2019
    Inventors: Jeremy Robert Greenwood, Craig E. Masse, Jon P. Lawson, Jean-Baptiste Arlin, David Pearson, Jonathan James Loughrey
  • Crystal forms of sialic acid or salt or solvate thereof
    Patent number: 10385085
    Abstract: The present invention includes crystalline forms of N-acetylneuraminic acid (NeuAc) and crystalline forms of salts and/or solvates of N-acetylneuraminic acid (NeuAc). Furthermore, the present invention provides compositions comprising these crystalline forms and therapeutic use of the crystalline forms.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: August 20, 2019
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: John Klopp, Hayley Reece, Jean-Baptiste Arlin, Corinna Marie Reisinger-Becker, Fabrice Dufour
  • TYK2 inhibitors, uses, and methods for production thereof
    Patent number: 10336752
    Abstract: The present invention provides compounds useful as inhibitors of Tyrosine Kinase 2 (Tyk2), solid forms and compositions thereof, methods of producing the same, and methods of using the same in the treatment of Tyk2-mediated diseases.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: July 2, 2019
    Assignee: Nimbus Lakshmi, Inc.
    Inventors: Jeremy Robert Greenwood, Jon P. Lawson, Craig E. Masse, Jean-Baptiste Arlin, David Pearson, Jonathan James Loughrey
  • TYK2 INHIBITORS, USES, AND METHODS FOR PRODUCTION THEREOF
    Publication number: 20180258086
    Abstract: The present invention provides compounds useful as inhibitors of Tyrosine Kinase 2 (Tyk2), solid forms and compositions thereof, methods of producing the same, and methods of using the same in the treatment of Tyk2-mediated diseases.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 13, 2018
    Inventors: Jeremy Robert Greenwood, Craig E. Masse, Jon P. Lawson, Jean-Baptiste Arlin, David Pearson, Jonathan James Loughrey
  • CRYSTAL FORMS OF SIALIC ACID OR SALT OR SOLVATE THEREOF
    Publication number: 20170073366
    Abstract: The present invention includes crystalline forms of N-acetylneuraminic acid (NeuAc) and crystalline forms of salts and/or solvates of N-acetylneuraminic acid (NeuAc). Furthermore, the present invention provides compositions comprising these crystalline forms and therapeutic use of the crystalline forms.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventors: John Klopp, Hayley Reece, Jean-Baptiste Arlin, Corinna Marie Reisinger-Becker, Fabrice Dufour